» Articles » PMID: 20223771

Genetic Instability Triggered by G-quadruplex Interacting Phen-DC Compounds in Saccharomyces Cerevisiae

Overview
Specialty Biochemistry
Date 2010 Mar 13
PMID 20223771
Citations 92
Authors
Affiliations
Soon will be listed here.
Abstract

G-quadruplexes are nucleic acid secondary structures for which many biological roles have been proposed but whose existence in vivo has remained elusive. To assess their formation, highly specific G-quadruplex ligands are needed. Here, we tested Phen-DC(3) and Phen-DC(6), two recently released ligands of the bisquinolinium class. In vitro, both compounds exhibit high affinity for the G4 formed by the human minisatellite CEB1 and inhibit efficiently their unwinding by the yeast Pif1 helicase. In vivo, both compounds rapidly induced recombination-dependent rearrangements of CEB1 inserted in the Saccharomyces cerevisiae genome, but did not affect the stability of other tandem repeats lacking G-quadruplex forming sequences. The rearrangements yielded simple-deletion, double-deletion or complex reshuffling of the polymorphic motif units, mimicking the phenotype of the Pif1 inactivation. Treatment of Pif1-deficient cells with the Phen-DC compounds further increased CEB1 instability, revealing additional G4 formation per cell. In sharp contrast, the commonly used N-methyl-mesoporphyrin IX G-quadruplex ligand did not affect CEB1 stability. Altogether, these results demonstrate that the Phen-DC bisquinolinium compounds are potent molecular tools for probing the formation of G-quadruplexes in vivo, interfere with their processing and elucidate their biological roles.

Citing Articles

Effects of hydrazone-based G-quadruplex ligands on -depleted cancer cells and a strain.

Germoglio M, DAria F, Cortone G, Prodomo A, Mahtab M, Morigi R NAR Cancer. 2025; 7(1):zcaf004.

PMID: 39927196 PMC: 11806260. DOI: 10.1093/narcan/zcaf004.


Benzimidazole-based small molecules as anticancer agents targeting telomeric G-quadruplex and inhibiting telomerase enzyme.

Elango H, Nath Das R, Saha A Future Med Chem. 2024; 16(19):2043-2067.

PMID: 39316718 PMC: 11485724. DOI: 10.1080/17568919.2024.2400982.


The age-related decline of helicase function-how G-quadruplex structures promote genome instability.

Frobel J, Hansel-Hertsch R FEBS Lett. 2024; 599(2):267-274.

PMID: 38803008 PMC: 11771695. DOI: 10.1002/1873-3468.14939.


Combating multidrug-resistance in : a G-quadruplex binding inhibitor of efflux pump and its bio-orthogonal assembly.

Chaudhuri R, Prasanth T, Biswas D, Mandal S, Dash J NAR Mol Med. 2024; 1(2):ugae005.

PMID: 38694210 PMC: 11059089. DOI: 10.1093/narmme/ugae005.


Stabilization of G-Quadruplex Structures of the SARS-CoV-2 Genome by TMPyP4, BRACO19, and PhenDC3.

Cervenak M, Molnar O, Horvath P, Smeller L Int J Mol Sci. 2024; 25(5).

PMID: 38473730 PMC: 10931149. DOI: 10.3390/ijms25052482.


References
1.
De Cian A, Delemos E, Mergny J, Teulade-Fichou M, Monchaud D . Highly efficient G-quadruplex recognition by bisquinolinium compounds. J Am Chem Soc. 2007; 129(7):1856-7. DOI: 10.1021/ja067352b. View

2.
Winzeler E, Shoemaker D, Astromoff A, Liang H, Anderson K, Andre B . Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science. 1999; 285(5429):901-6. DOI: 10.1126/science.285.5429.901. View

3.
De Cian A, Cristofari G, Reichenbach P, De Lemos E, Monchaud D, Teulade-Fichou M . Reevaluation of telomerase inhibition by quadruplex ligands and their mechanisms of action. Proc Natl Acad Sci U S A. 2007; 104(44):17347-52. PMC: 2077259. DOI: 10.1073/pnas.0707365104. View

4.
De Cian A, Lacroix L, Douarre C, Temime-Smaali N, Trentesaux C, Riou J . Targeting telomeres and telomerase. Biochimie. 2007; 90(1):131-55. DOI: 10.1016/j.biochi.2007.07.011. View

5.
Hershman S, Chen Q, Lee J, Kozak M, Yue P, Wang L . Genomic distribution and functional analyses of potential G-quadruplex-forming sequences in Saccharomyces cerevisiae. Nucleic Acids Res. 2007; 36(1):144-56. PMC: 2248735. DOI: 10.1093/nar/gkm986. View